Market Overview

UPDATE: JP Morgan Downgrades Mead Johnson Nutrition to Neutral on Top-Line Concerns

Related MJN
Will ConAgra (CAG) Miss Earnings Estimates? - Analyst Blog
Market Wrap For February 19: Stocks Close Lower, Nasdaq Ends Winning Streak

JP Morgan downgraded Mead Johnson Nutrition Company (NYSE: MJN) from Overweight to Neutral and lowered the price target from $71.00 to $68.00.

JP Morgan said, "With the stock trading at 20.5x NTM P/E and 13.2x EV/EBITDA, valuation metrics are near the high end of all consumer staples despite a great deal of uncertainty around near-term fundamentals. We are increasingly concerned about the top-line potential in 2013, and we think margins will get hit in 2H13 by higher dairy costs. We still consider MJN a fundamentally strong company but would look for a better entry point before buying the shares."

Mead Johnson Nutrition closed at $66.96 on Wednesday.

Posted-In: JP MorganAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Most Popular

Related Articles (MJN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free